Literature DB >> 26169652

Response to Letter Regarding Article, "The ERG-APLNR Axis Controls Pulmonary Venule Endothelial Proliferation in Pulmonary Veno-Occlusive Disease".

Christopher Lathen1, Yu Zhang1, Jennifer Chow1, Martanday Singh1, Grace Lin2, Vishal Nigam3, Yasser A Ashraf1, Jason X Yuan4, Ivan M Robbins5, Patricia A Thistlethwaite1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26169652      PMCID： PMC4624330          DOI： 10.1161/CIRCULATIONAHA.114.014783

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo.

Authors:  Christopher M Cox; Susan L D'Agostino; Melanie K Miller; Ronald L Heimark; Paul A Krieg
Journal:  Dev Biol       Date:  2006-04-27       Impact factor: 3.582

2.  ERG-APLNR axis controls pulmonary venule endothelial proliferation in pulmonary veno-occlusive disease.

Authors:  Christopher Lathen; Yu Zhang; Jennifer Chow; Martanday Singh; Grace Lin; Vishal Nigam; Yasser A Ashraf; Jason X Yuan; Ivan M Robbins; Patricia A Thistlethwaite
Journal:  Circulation       Date:  2014-07-25       Impact factor: 29.690

3.  Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis.

Authors:  Mélanie Eyries; Géraldine Siegfried; Mariana Ciumas; Kevin Montagne; Monique Agrapart; Franck Lebrin; Florent Soubrier
Journal:  Circ Res       Date:  2008-07-10       Impact factor: 17.367

4.  Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats.

Authors:  Xing Cheng; Xiao Shuo Cheng; Catherine C Y Pang
Journal:  Eur J Pharmacol       Date:  2003-06-06       Impact factor: 4.432
  4 in total
  1 in total

1.  Noninvasive Prenatal Diagnosis Significance of ERG Methylation as a Biomarker in Down's Syndrome.

Authors:  Xiangju Liu; Ming Xue
Journal:  Med Sci Monit       Date:  2017-01-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.